Pregnancy Could Help Reduce the Risk of Long COVID
Drug Topics
APRIL 2, 2025
A study found that patients who acquired a SARS-CoV-2 infection during pregnancy had a lower risk of developing long COVID compared to those who were not pregnant.
Drug Topics
APRIL 2, 2025
A study found that patients who acquired a SARS-CoV-2 infection during pregnancy had a lower risk of developing long COVID compared to those who were not pregnant.
PharmaVoice
APRIL 2, 2025
Amid widespread staff reductions at health agencies, a number of key officials have bid farewell to pharma’s top regulator.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 2, 2025
All 3 types of virtual diabetes self-management interventions lead to better results in hemoglobin A1c over a 6-month period.
STAT
APRIL 2, 2025
WASHINGTON — Marty Makary’s first address to staff as FDA commissioner on Wednesday afternoon sounded a bit like an introduction to one of his books. It included sweeping declarations about the need to challenge scientific norms, and to identify the root causes of chronic disease. Makary sprinkled in anecdotes intended to stir emotion, recounting the time when his father gave a cancer patient a hug at the grocery store.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 2, 2025
Researchers conducted a comprehensive review of allergic contact dermatitis, detailing the conditions epidemiology, pathophysiology, clinical manifestations, diagnostic approaches, and therapeutic options.
Pharma Marketing Network
APRIL 2, 2025
Introduction If the past few years have taught pharma marketers anything, it’s that agility, data, and digital-first thinking aren’t just buzzwordsthey’re survival tactics. Marketing in pharma has undergone a radical shift, propelled by digital transformation, patient-centric demands, and evolving regulatory landscapes. In 2025, the strategies that succeed are rooted in personalization, innovation, and real-time adaptability.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
APRIL 2, 2025
By cutting the Provider Relief Bureau, RFK Jr.'s HHS has lost the staff expertise to reclaim more than a billion dollars in payments made to providers during the COVID-19 pandemic. The move seems antithetical to the workforce reduction effort's aim to save taxpayer dollars.
Drug Topics
APRIL 2, 2025
Pharmacists can help manage complications from long COVID-19, as no medications can treat it.
Fierce Healthcare
APRIL 2, 2025
The agency submitted an order this week seeking an administrative stay in the case, as there are currently no sitting commissioners who are able to join the proceedings.
Drug Topics
APRIL 2, 2025
The integration of CGM into pharmacy practice represents a significant opportunity for pharmacists to provide enhanced patient care.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Oswald's
APRIL 2, 2025
The words fish oil invoke a particular disgust response in me every time I hear them. As a non-fish eater, I get annoyed by the onslaught of supposed health benefits of eating fish and/or taking fish oil supplements. I wanted to dive into whats good, whats bad, and if there are any options out there for those of us who may be vegetarian or dont eat fish.
Drug Topics
APRIL 2, 2025
Glucocorticoid use for severe community-acquired pneumonia has been controversial due to the safety profile of these drugs.
Pharmacy Times
APRIL 2, 2025
The only major change is in the included strain of influenza A/H2N2 virus, which has been updated for both the egg-based and the cell- and recombinant-based vaccines.
STAT
APRIL 2, 2025
Dear Readers: Shortly after sunrise on Tuesday, STAT reporters around the county started their days with a deluge of alarmed, angry, and plaintive texts, emails, and even phone calls from employees across federal health agencies who just learned they had lost their jobs.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Oswald's
APRIL 2, 2025
As we settle into Spring celebrating our 150th year in business, theres been a big shake-up in the world of pharmacy. If you caught the news last month, you may have seen that Sycamore Partners, a private equity firm, is purchasing Walgreens. The same company that owns The Limited, Hot Topic, and Staples is now in charge of one of Americas largest drugstore chains.
Pharmacy Times
APRIL 2, 2025
The Auto-Pure 2400 system combines liquid handling and magnetic cell isolation for efficient latent tuberculosis testing.
Pharmaceutical Technology
APRIL 2, 2025
Amneal Pharmaceuticals, along with Shilpa Medicare, has launched the new presentation of bortezomib, Boruzu.
pharmaphorum
APRIL 2, 2025
Johnson & Johnson's third attempt to use bankruptcy proceedings to settle lawsuits claiming its talc-based products harmed consumers has failed
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
APRIL 2, 2025
Senior Writer Paige Minemyer sat down with Soo Jeon, the head of the accelerator at Healthworx, to dig into how the team works with burgeoning startups and what results theyve seen so far.
pharmaphorum
APRIL 2, 2025
Prosecutors in the US are seeking the death penalty for Luigi Mangione in connection with the assassination of UnitedHealth CEO Brian Thompson.
Fierce Healthcare
APRIL 2, 2025
Carrum Health has expanded its network to over 1,000 locations and has extended its specialty care offerings to new categories that all together cover 40% of employer medical spend.
Pharmacy Times
APRIL 2, 2025
Nicolas Girard, MD, explains the benefits observed in the MARIPOSA clinical trial among patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) treated with amivantamab plus lazertinib.
Fierce Healthcare
APRIL 2, 2025
Enrollment on the Affordable Care Act's exchanges has more than doubled over the past several years, with much of that growth coming from red states, according to a new report.
Pharmacy Times
APRIL 2, 2025
Pharmacists play a crucial role in educating patients on proper administration and adherence to GLP-1 treatments.
pharmaphorum
APRIL 2, 2025
Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated late-stage Hodgkin lymphoma
Pharmacy Times
APRIL 2, 2025
These new phase 3 results indicate the effectiveness of the 2-dose 13-valent pneumococcal conjugate vaccine (PCV13) and 1-dose PCV20 regimens.
Fierce Healthcare
APRIL 2, 2025
Apree Health has a new CEO, Jon Porter, who has a bold vision to refocus the company on its digital roots.
Pharmacy Times
APRIL 2, 2025
Pharmacists performed weekly toxicity and tumor lysis syndrome monitoring.
Pharmaceutical Technology
APRIL 2, 2025
At the BioTrinity Conference, experts champion government funding programmes to bridge gap the in UK venture capital financing.
Pharmacy Times
APRIL 2, 2025
By decades end, approval of additional bispecifics is expected for hematological malignancies, solid tumors, and non-oncology conditions such as inflammatory, autoimmune, neurodegenerative and vascular diseases, and ocular disorders and infections.
Pharmaceutical Commerce
APRIL 2, 2025
The latest news for pharma industry insiders.
Pharmacy Times
APRIL 2, 2025
Similar legislation could also address PBM practices in commercial insurance.
Pharmaceutical Commerce
APRIL 2, 2025
In the first part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Kimberly Westrich, chief strategy officer at the National Pharmaceutical Council, lays out the basics surrounding accumulators, maximizers, and AFPs.
Let's personalize your content